Product Information

DOXEPIN HCL 3 MG TABLET is a generic product labeled by Viona Pharmaceuticals Inc., priced at $1.3184 per EA under NDC 72578018106. Its NADAC has been published 94 times since Feb 5, 2025.

FDA first approved this application on Aug 16, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DOXEPIN HCL 3 MG TABLET

doxepin
$1.3184per EA

Strength

3 mg/1

NDC

72578018106

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

DOXEPIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202761

FDA Approved

8/16/2023

TE Code

AB

On Market Since

6/30/2024

Pharmacological Classes

Price Statistics

The NADAC for DOXEPIN HCL 3 MG TABLET has been published 94 times since Feb 5, 2025, and over the history we have for it it has declined 49.8%. The table below summarizes its recorded NADAC range and movement.

Current price$1.3184 per EA
All-time high$2.7414 (Apr 16, 2025)
All-time low$1.3184 (Nov 18, 2026)
52-week high$2.0842
52-week low$1.3184
Median price$1.9518
Average price$1.8887
Largest weekly change-16.0% (Jan 21, 2026)
Weeks tracked94
Tracking sinceFeb 5, 2025

Price History

1W

-3.4%

1M

-1.1%

3M

-3.4%

6M

-12.6%

1Y

-36.7%

3Y

N/A

5Y

N/A

All

-49.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the doxepin market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of DOXEPIN HCL 3 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for DOXEPIN HCL 3 MG TABLET, manufactured by Viona Pharmaceuticals Inc., is $1.3184 per EA (NDC 72578018106), effective Nov 18, 2026.

How has the price of DOXEPIN HCL 3 MG TABLET changed over time?

Over the history we have for it, the NADAC for DOXEPIN HCL 3 MG TABLET has declined 49.8%. It has been tracked across 94 weekly CMS publications since Feb 5, 2025.

What are the highest and lowest recorded NADAC prices for DOXEPIN HCL 3 MG TABLET?

Since Feb 5, 2025, the NADAC for DOXEPIN HCL 3 MG TABLET has ranged from a low of $1.3184 (Nov 18, 2026) to a high of $2.7414 (Apr 16, 2025), with a median of $1.9518 per EA.

Are there cheaper alternatives to DOXEPIN HCL 3 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of DOXEPIN HCL 3 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures DOXEPIN HCL 3 MG TABLET?

DOXEPIN HCL 3 MG TABLET (NDC 72578018106) is labeled by Viona Pharmaceuticals Inc., and CMS classifies it as a generic product.